In vitro studies of RCC-predisposing Type 2A and Type 2B VHL missense mutations have revealed a correlation between the degree of mutant pVHL-mediated HIF-α dysregulation and risk of ccRCC [24]. Here, VHL is linked to nonpapillary renal cell carcinoma.